BCMA/CD3 BsAb Therapy for POEMS Syndrome
Clinical trial NCT07115654 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07115654
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-10
- Primary completion
- 2026-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.